Jean Franchi

Jean Franchi currently serves as Chief Financial Officer at Disc Medicine since February 2024. Previously, Franchi held multiple roles, including Chief Financial Officer, Treasurer, Secretary, and Compliance Officer at Replimune from December 2019 to June 2023, and similar positions at Dimension Therapeutics from August 2015 to July 2017. Franchi was Chief Financial Officer at Merrimack Pharmaceuticals from August 2017 to June 2019 and at Good Start Genetics from February 2012 to July 2015. A significant tenure at Genzyme from 1995 to 2011 encompassed roles such as SVP of Corporate Finance and VP of Finance. Earlier experience includes financial analysis positions at bioMerieux and AHP (API Division). Franchi earned a BA in Business Administration with a focus in Accounting from Hofstra University.